Neupath Health Stock Today
| NPTH Stock | CAD 0.51 0.05 8.93% |
PerformanceFair
| Odds Of DistressSmall
|
NeuPath Health is selling for under 0.51 as of the 27th of January 2026; that is 8.93 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.51. NeuPath Health has about a 36 percent probability of financial distress in the next few years of operation but had a somewhat fair performance during the last 90 days. The performance scores are derived for the period starting the 29th of October 2025 and ending today, the 27th of January 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange.. The company has 56.6 M outstanding shares of which 478 shares are now shorted by private and institutional investors with about 0.0 days to cover all short positions. More on NeuPath Health
Moving together with NeuPath Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
NeuPath Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NeuPath Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NeuPath Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | BA CPA | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Management, Management, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | ||||
NeuPath Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to NeuPath Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
NeuPath Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NeuPath Health's financial leverage. It provides some insight into what part of NeuPath Health's total assets is financed by creditors.
| |||||
NeuPath Health (NPTH) is traded on TSX Venture Exchange in Canada and employs 148 people. NeuPath Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeuPath Health's market, we take the total number of its shares issued and multiply it by NeuPath Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NeuPath Health operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 56.6 M outstanding shares of which 478 shares are now shorted by private and institutional investors with about 0.0 days to cover all short positions.
NeuPath Health has accumulated about 7.48 M in cash with 2.61 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check NeuPath Health Probability Of Bankruptcy
Ownership AllocationNeuPath Health maintains a total of 56.6 Million outstanding shares. Roughly 80.61 % of NeuPath Health outstanding shares are held by general public with 1.68 pct. owned by insiders and only 17.71 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check NeuPath Ownership Details
NeuPath Health Historical Income Statement
NeuPath Stock Against Markets
NeuPath Stock Analysis Notes
About 18.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.5. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeuPath Health recorded a loss per share of 0.01. The entity last dividend was issued on the 6th of July 2020. NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange. To find out more about NeuPath Health contact the company at 905 858 1368 or learn more at https://www.neupath.com.NeuPath Health Quarterly Total Revenue |
|
NeuPath Health Investment Alerts
| NeuPath Health has some characteristics of a very speculative penny stock | |
| NeuPath Health appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 72.81 M. Net Loss for the year was (728 K) with profit before overhead, payroll, taxes, and interest of 15.16 M. | |
| Latest headline from news.google.com: NeuPath Health announces CEO transition and preliminary 2025 results - Investing.com |
NeuPath Largest EPS Surprises
Earnings surprises can significantly impact NeuPath Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-03-16 | 2021-12-31 | 0.01 | -0.0155 | -0.0255 | 255 |
NeuPath Health Thematic Classifications
In addition to having NeuPath Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Health ManagementHealthcare providers, hospitals | |
 | ManagementManagement services |
NeuPath Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeuPath Health's market, we take the total number of its shares issued and multiply it by NeuPath Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.NeuPath Profitablity
NeuPath Health's profitability indicators refer to fundamental financial ratios that showcase NeuPath Health's ability to generate income relative to its revenue or operating costs. If, let's say, NeuPath Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, NeuPath Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of NeuPath Health's profitability requires more research than a typical breakdown of NeuPath Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Management Efficiency
NeuPath Health has return on total asset (ROA) of 0.0288 % which means that it generated a profit of $0.0288 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0224) %, meaning that it generated substantial loss on money invested by shareholders. NeuPath Health's management efficiency ratios could be used to measure how well NeuPath Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, NeuPath Health's Net Tangible Assets are fairly stable compared to the past year. Intangible Assets is likely to climb to about 1.1 M in 2026, whereas Other Current Assets are likely to drop slightly above 591.2 K in 2026.Examining the leadership quality of NeuPath Health offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Technical Drivers
As of the 27th of January, NeuPath Health secures the Mean Deviation of 2.91, downside deviation of 4.53, and Risk Adjusted Performance of 0.0972. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NeuPath Health, as well as the relationship between them. Please verify NeuPath Health treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside to decide if NeuPath Health is priced some-what accurately, providing market reflects its recent price of 0.51 per share.NeuPath Health Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. NeuPath Health Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe NeuPath Health price patterns.
NeuPath Health Predictive Daily Indicators
NeuPath Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NeuPath Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NeuPath Health Forecast Models
NeuPath Health's time-series forecasting models are one of many NeuPath Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NeuPath Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in NeuPath Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.